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ABSTRACT 
The rate of infertility in married couples of reproductive age in this country 
makes up from 10 to 15%, in some regions this value is close to 20% - a 
critical level that has a negative impact on demographic figures. The rate 
of pregnancy depends directly on the women’s age and decreases by 3.3 
times starting from the age of 19 and by the age of 48. The decrease in the 
ability to conceive is accounted for by subtle mechanisms related to the 
deterioration of the quality of oocytes. The patients who are prepared for 
an extracorporeal fertilization program (ECF) and do not respond to 
controlled ovarian hyperstimulation protocols are considered to be poor 
respondents. Many studies focused on the development of an optimal 
treatment method. However, none of the approaches seems to be effective 
enough to guarantee a successful use. Platelet-rich plasma is a new and 
promising method that is successfully used in the reproductive science to 
solve a number of medical problems. All the patients whose common 
features were low oocyte output and poor embryo quality as well as failed 
ECF attempts were offered a treatment method of autologous PRP therapy 
after their written consent. Three months later, one obtained astonishing 
results, which by the markers of biochemical infertility alone could be 
classified as a complete biological phenomenon and are also characterized 
by improved embryo quality. The results of hormonal homeostasis show a 
decrease in the level of the follicle-stimulating hormone by 67.33% while 
the level of the anti-muellerian hormone is 75.18% higher. 
Thus, the use of the PRP therapy in poor respondents helps them to 
overcome their problematic reproductive barrier. 
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Introduction. The rate of infertility in married couples of reproductive age in this country 
makes up from 10 to 15 %, in some regions this value is close to 20% - a critical level that has a 
negative impact on demographic figures. The rate of pregnancy depends directly on the women’s age 
and decreases by 3.3 times starting from the age of 19 and by the age of 48 [1,2]. 
A significant part of women seeking treatment for infertility at the clinics that use assisted 
reproductive technologies (ART) are women of the late reproductive age [3,4]. 
Indeed, the postponing of marriage and pregnancy by women of reproductive age has led to an 
increase in the rate of age-related infertility in recent years. The ovarian reserve of such women is 
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significantly reduced, often close to zero. Besides, such women usually have a positive gynecological 
anamnesis (endometriosis, uterine fibroids, surgeries on small pelvis organs, etc.). 
The key factors influencing the efficiency of ART attempts include a reduced ovarian reserve 
(age factor, surgeries on ovaries, endocrine disorders) and ovarian insufficiency with normal 
gonadotropin levels. To improve the ovarian response in patients of the late reproductive age with a 
low ovarian reserve, various stimulation methods are offered: the use of short stimulation protocols, 
the reduction of the dose of gonadotropin-releasing hormone agonists (GnRH-a), the use of 
gonadotropin-releasing hormone antagonists (GnRH-ant), etc. [5,6,7]. However, the key component of 
these modified protocols is the increase of the dose of gonadotropin, i.e. a more aggressive ovarian 
stimulation. The efficiency of these strategies arouses doubt [8]. 
Research aim. Assessment of the efficiency of the use of the PRP therapy to activate 
folliculogenesis in women of the late reproductive age by means of hormonal and ultrasound 
examination of the ovarian function. 
Research data. The research was aimed at establishing whether the quantity of follicles in 
women of the late reproductive age would increase after the intraovarian injection of autologous PRP. 
The research was conducted on 42 women affected by infertility and aged between 35 and 44 
(average age 37.6±4.2 years). The functional condition of the hypophysial and ovarian system was 
examined with the use of hormonal, biochemical and ultrasound methods. The retrospective analysis 
of data included the indicators of the socioeconomic situation, somatic, gynecological, obstetrical and 
allergological anamnesis. All the women underwent a complete clinical and laboratory examination. 
All the women underwent transabdominal and transvaginal ultrasonography of the small 
pelvis organs (convex sensors of 3-5 and 5-9 MHz) with the use of an SSD-500 diagnostic ultrasound 
scanner. When examining ovaries, one measured their volume and the ovarian-uterine index (OUI) 
according to S.G. Khachkaruzov’s method (1999). 
The levels of hormones in blood serum was measured with the use of immunoenzyme assay 
on the 2-3d day of the menstrual cycle. 
The research results were processed by means of the applied program package Exel-2007 and 
Statistica 5а. In the course of statistical analysis, we calculated the significance level (p), with 0.05 
being the critical value. 
Research results. 
The experience of use of ART shows that the use of inducers of folliculogenesis in the most 
common stimulation protocols (usually long stimulation protocols) allows the maturation of no more 
than 3 follicles (or none at all) in 20 to 30% of patients in the first treatment cycle. A decreased 
ovarian response to inducers of folliculogenesis is referred to as poor or low. Our task was to find a 
simple and effective way of use of the PRP therapy, which in its turn would stimulate ovulation, to 
activate folliculogenesis in women of the late reproductive age with a low ovarian reserve by 
rejuvenation of ovaries with autologous PRP, stimulating and differentiating stem cells, with the 
formation of new follicles, to ensure the stimulation of folliculogenesis in a way that would be not too 
aggressive, economically reasonable and at the same time would increase the prospects of pregnancy. 
The set objective of activation of folliculogenesis in women of the late reproductive was accomplished 
by the infusion of autologous PRP, which, according to the invention, implied the activation of 
intracellular and signaling pathways that induced the mechanisms of reparation by proliferation and 
differentiation of cells of mesenchymal origin in women of the late reproductive age with a low 
ovarian reserve (poor response, failed ECF attempts, low oocyte output and poor embryo quality). 
The suggested method, consisting of 2 stages, enables the activation of intracellular and 
signaling pathways. In the first stage, 20 ml of blood is collected from every patient and placed into a 
vessel with sodium citrate that prevents platelet aggregation, with subsequent transvaginal injection of 
4 ml of the obtained material directly in each ovary with a puncture needle under sonographic control. 
The course of treatment implies 4 injections and lasts for three months. The stimulating effect is 
reached if the platelet concentration in PRP exceeds 1,000,000/μl. 
The mean numbers of oocytes before and after the PRP injection were 0.64 and 2.1 
respectively. Two patients had spontaneous conceptions. The third patient reached clinical pregnancy 
and gave birth to a healthy child in June 2018. The results of this research are probably the first report 
on the influence of the intraovarian PRP injection on the increase of the ovarian response, even on 
spontaneous responses of women with a poor ovarian response. 
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Intraovarian PRP injection is a new treatment approach for patients of the late reproductive 
age with a low ovarian reserve. In our research, the said method led to successful pregnancy and live 
birth in 18 patients, which makes up 42.8%. The analysis of the indicators of hormonal homeostasis 
revealed an increase in the basic levels of gonadotropins in women of the late reproductive age, 
namely of FSH by 3 times to 12.8±1.5 IU/l and of LH by 2.8 times to 12.6±1.4 IU/l, while the level of 
AMH ranged from 0.7 to 0.9 ng/ml. After 3 months of the suggested therapy, the levels of FDH 
decreased to 7.8±1.2 IU/l and of LH to 8.1±1.4 IU/l, while AMH ranged from 1.1 to 1.3 ng/ml. Before 
the treatment, the level of estradiol in blood serum was decreased by 2 times to 0.13±0.02 nmol/l and 
after the treatment, it increased to 0.22±0.03 nmol/l, which corresponded with the levels in the early 
follicular phase of the menstrual cycle. As for the number of antral follicles, it clearly correlates with 
the patients’ age. Thus, in women aged between 36 and 41, the mean number of follicles was 4.5±1.7, 
in women aged between 42 and 44, the mean number of follicles was 3.7±1.4 in 75 (27.6%) cases. 
After the suggested therapy, the number of antral follicles increased statistically significantly to 
8.4±1.5 in women aged between 36 and 41 and to 7.6±1.2 in women aged between 42 and 44. 
Thus, after 3 months of the suggested therapy, the levels of the examined hormones did not differ 
from the levels in healthy women of reproductive age, which confirms the efficiency of the treatment. 
Conclusions. Judging by the totality of significant features, we have obtained a new technical 
solution that ensures a qualitatively new result, including the improvement of blood supply in tissues 
owing to improved angiogenesis and the activation of folliculogenesis in ovaries, with the formation 
of new follicles, in women of the late reproductive age, and may be used in ART programs. This result 
is sufficient for the set objective to be accomplished. 
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